80 participants
Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2007-08-03
- Start Date:
- 2004-01-31
Conditions
- Myeloid Leukemia, Chronic, Chronic-Phase
Interventions
- DRUG
No Results Yet